New inquest indicates that giving profession a constant low dose of an immune system booster, a method known as metronomic dosing, as part of a medical prostate cancer vaccine artifice is safe and produces similar immune responses and fewer side effects than the more common dosing method, which is not well tolerated by many patients. This study, led by researchers at that subject Cancer edit (NCI), part of the subject Institutes of Health, was published in the Aug. 15, 2008, issue of Clinical Cancer Research.

More: - From the site